Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation
Surbhi Sarna sold her last startup, nVision Medical, for $275 million. Now she's leaving a partner role at Y Combinator to launch Collate … Bluesky: @alexrkonrad . LinkedIn: Josh Kopelman , Alex Konrad , Collate , Sarah Guo , and Surbhi Sarna Bluesky: Alex Konrad / @alexrkonrad : Exclusive: Y Combinator partner Surbhi Sarna has raised $30 million for a new startup, Collate, looking to bring AI to tedious paperwork for life sciences companies. — @amyfeldman7.bsky.social and I spoke to Sarna, who previously built and sold medical device startup nVision Medical, for @forbes.com. LinkedIn: Josh Kopelman : Excited to partner with Surbhi Sarna and the Collate team on their mission to let life science companies focus on what matters most (advancing human health) by minimizing the burden of documentation! Alex Konrad : News: Y Combinator partner Surbhi Sarna has raised $30 million for a new startup, Collate, looking to bring AI to tedious paperwork for life sciences companies. … Collate : Surbhi Sarna, CEO and Founder of Collate, announces our $30M seed round led by Satish Dharmaraj at Redpoint, Josh Kopelman at First Round Capital, Sarah Guo at Conviction, and Y Combinator. Sarah Guo : Surbhi Sarna is an unstoppable force. I asked if we could invest one sentence into our first conversation about her starting another company. … Surbhi Sarna : Introducing Collate and announcing our $30M seed round — A few months ago, the symptoms returned: Midnight note-taking. A whiteboard in my shower. …